Literature DB >> 33635274

Personal Accounts of Young-Onset Colorectal Cancer Organized as Patient-Reported Data: Protocol for a Mixed Methods Study.

Klay Lamprell1, Diana Fajardo Pulido1, Yvonne Tran1, Bróna Nic Giolla Easpaig1, Winston Liauw2, Gaston Arnolda1, Jeffrey Braithwaite1.   

Abstract

BACKGROUND: Young-onset colorectal cancer is a contemporary issue in need of substantial research input. The incidence of colorectal cancer in adults younger than 50 years is rising in contrast to the decreasing incidence of this cancer in older adults. People with young-onset colorectal cancer may be at that stage of life in which they are establishing their careers, building relationships with long-term partners, raising children, and assembling a financial base for the future. A qualitative study designed to facilitate triangulation with extant quantitative patient-reported data would contribute the first comprehensive resource for understanding how this distinct patient population experiences health services and the outcomes of care throughout the patient pathway.
OBJECTIVE: The aim of this study was to undertake a mixed-methods study of qualitative patient-reported data on young-onset colorectal cancer experiences and outcomes.
METHODS: This is a study of web-based unsolicited patient stories recounting experiences of health services and clinical outcomes related to young-onset colorectal cancer. Personal Recollections Organized as Data (PROD) is a novel methodology for understanding patients' health experiences in order to improve care. PROD pivots qualitative data collection and analysis around the validated domains and dimensions measured in patient-reported outcome and patient-reported experience questionnaires. PROD involves 4 processes: (1) classifying attributes of the contributing patients, their disease states, their routes to diagnosis, and the clinical features of their treatment and posttreatment; (2) coding texts into the patient-reported experience and patient-reported outcome domains and dimensions, defined a priori, according to phases of the patient pathway; (3) thematic analysis of content within and across each domain; and (4) quantitative text analysis of the narrative content.
RESULTS: Relevant patient stories have been identified, and permission has been obtained for use of the texts in primary research. The approval for this study was granted by the Macquarie University Human Research Ethics Committee in June 2020. The analytical framework was established in September 2020, and data collection commenced in October 2020. We will complete the analysis in March 2021 and we aim to publish the results in mid-2021.
CONCLUSIONS: The findings of this study will identify areas for improvement in the PROD methodology and inform the development of a large-scale study of young-onset colorectal cancer patient narratives. We believe that this will be the first qualitative study to identify and describe the patient pathway from symptom self-identification to help-seeking through to diagnosis, treatment, and to survivorship or palliation for people with young-onset colorectal cancer. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/25056. ©Klay Lamprell, Diana Fajardo Pulido, Yvonne Tran, Bróna Nic Giolla Easpaig, Winston Liauw, Gaston Arnolda, Jeffrey Braithwaite. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 26.02.2021.

Entities:  

Keywords:  PROMs; cancer; colorectal cancer; patient reported outcome; young-onset cancer

Year:  2021        PMID: 33635274      PMCID: PMC7954655          DOI: 10.2196/25056

Source DB:  PubMed          Journal:  JMIR Res Protoc        ISSN: 1929-0748


  53 in total

1.  Classifying the findings in qualitative studies.

Authors:  Margarete Sandelowski; Julie Barroso
Journal:  Qual Health Res       Date:  2003-09

2.  Analytical Insights from Patient Narratives: The Next Step for Better Patient Experience.

Authors:  Cheristi Cognetta-Rieke; Senem Guney
Journal:  J Patient Exp       Date:  2014-05-01

3.  The increasing incidence of young-onset colorectal cancer: a call to action.

Authors:  Dennis J Ahnen; Sally W Wade; Whitney F Jones; Randa Sifri; Jose Mendoza Silveiras; Jasmine Greenamyer; Stephanie Guiffre; Jennifer Axilbund; Andrew Spiegel; Y Nancy You
Journal:  Mayo Clin Proc       Date:  2014-01-04       Impact factor: 7.616

4.  Data collection strategies for patient-reported information.

Authors:  D F Cella; S R Lloyd
Journal:  Qual Manag Health Care       Date:  1994       Impact factor: 0.926

Review 5.  The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment.

Authors:  Louise C Connell; José Mauricio Mota; Maria Ignez Braghiroli; Paulo M Hoff
Journal:  Curr Treat Options Oncol       Date:  2017-04

6.  A systematic review of evidence on the links between patient experience and clinical safety and effectiveness.

Authors:  Cathal Doyle; Laura Lennox; Derek Bell
Journal:  BMJ Open       Date:  2013-01-03       Impact factor: 2.692

7.  Simple rules for evidence translation in complex systems: A qualitative study.

Authors:  Julie E Reed; Cathy Howe; Cathal Doyle; Derek Bell
Journal:  BMC Med       Date:  2018-06-20       Impact factor: 8.775

8.  What information do patients want across their cancer journeys? A network analysis of cancer patients' information needs.

Authors:  Yvonne Tran; Klay Lamprell; Brona Nic Giolla Easpaig; Gaston Arnolda; Jeffrey Braithwaite
Journal:  Cancer Med       Date:  2018-12-07       Impact factor: 4.452

9.  Using patients' experiences to identify priorities for quality improvement in breast cancer care: patient narratives, surveys or both?

Authors:  Vicki Tsianakas; Jill Maben; Theresa Wiseman; Glenn Robert; Alison Richardson; Peter Madden; Mairead Griffin; Elizabeth A Davies
Journal:  BMC Health Serv Res       Date:  2012-08-22       Impact factor: 2.655

10.  Assessment of patient centredness through patient-reported experience measures (ASPIRED): protocol of a mixed-methods study.

Authors:  Eva Christalle; Stefan Zeh; Pola Hahlweg; Levente Kriston; Martin Härter; Isabelle Scholl
Journal:  BMJ Open       Date:  2018-10-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.